Companies purpose as In order to reduce costs and increase spending in uncertain macroeconomic conditions, FormBio thinks it is the right time to launch the platform. The software company was developed by Colossal Biosciences — best known for its mission to bring extinct creatures like the woolly mammoth back to life — and is now striking out on its own.
Software FormBio is designed to bring workflow solutions to the computational biology space, which includes data and modeling for understanding biological systems and fields such as gene therapy and biotech.
The platform uses machine learning to help researchers and companies move from idea to scientific discovery faster, simplifying the data analysis process in between and allowing users to choose from customizable workflow templates to suit a company’s unique needs.
FormBio announced on September 27 that it was spinning off from Colossal Biosciences in a $30 million round of funding led by Jazz Venture Partners and Thomas Tull, both Colossal Biosciences investors.
Kent Wakeford, CEO of both FormBio and Colossal, got the idea for FormBio when they were trying to get started on day one of the Colossal journey and realized there was no one-stop software they could use.
